Inotiv (NOTVQ) Other Accumulated Expenses (2021 - 2022)

Inotiv's (NOTVQ) quarterly Other Accumulated Expenses came in at $3.1 million in Q2 2022, up 1850.63% on a QoQ basis from $160000.0 in Q1 2022.

Inotiv (NOTVQ) Other Accumulated Expenses (2021 - 2022) Analysis & Trends

Inotiv (NOTVQ) has 2 years of Other Accumulated Expenses data on file, last reported at $3.1 million in Q2 2022.

Quarterly Other Accumulated Expenses changed N/A year-over-year to $3.1 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $3.1 million (changed N/A YoY) and the FY2021 annual result came in at $366000.0, changed N/A from the prior year.
Other Accumulated Expenses rose to $3.1 million in Q2 2022, from $160000.0 in the prior quarter.
In the past five years, Other Accumulated Expenses ranged from a high of $8.1 million in Q4 2021 to a low of $160000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	Inotiv	348,881.46	-14.83 Mn	111.99 Mn

Download Data